Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$5.01bn227.16n/a
au flag iconMSBMesoblastAU$3.40bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$977.27mn/an/a
au flag iconPYCPYC TherapeuticsAU$870.84mn/an/a
au flag iconRACRace OncologyAU$498.65mn/an/a
au flag iconCGSCogstateAU$429.07m28.790.78%
au flag iconIMMImmutepAU$379.70mn/an/a
au flag iconDXBDimerixAU$335.17mn/an/a
au flag iconTTXTetratherixAU$187.23mn/an/a
au flag iconACWActinogen MedicalAU$181.10mn/an/a
au flag iconNYRNyradaAU$160.30mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$140.19mn/an/a
au flag iconILAIsland PharmaceuticalsAU$125.13mn/an/a
au flag iconALAArovella TherapeuticsAU$95.09mn/an/a
au flag iconBXNBioxyneAU$82.26m16.67n/a
au flag iconLTPLtr PharmaAU$76.01mn/an/a
au flag iconATHAlterity TherapeuticsAU$73.02mn/an/a
au flag iconIMUImugeneAU$70.01mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$69.50mn/an/a
au flag iconPTXPrescient TherapeuticsAU$69.26mn/an/a